Tryngolza™ (olezarsen) – New orphan drug approval
December 19, 2024 - Ionis Pharmaceuticals announced the FDA approval of Tryngolza (olezarsen), as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).
December 19, 2024 - Ionis Pharmaceuticals announced the FDA approval of Tryngolza (olezarsen), as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).